Cargando…

Recent common human coronavirus infection protects against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection: A Veterans Affairs cohort study

Detalles Bibliográficos
Autores principales:	Fillmore, Nathanael R., Szalat, Raphael E., La, Jennifer, Branch-Elliman, Westyn, Monach, Paul A., Nguyen, Vinh, Samur, Mehmet K., Brophy, Mary T., Do, Nhan V., Munshi, Nikhil C.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	National Academy of Sciences 2022
Materias:	Letters
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9674225/ https://www.ncbi.nlm.nih.gov/pubmed/36343242 http://dx.doi.org/10.1073/pnas.2213783119

Ejemplares similares

Increased COVID-19 Breakthrough Infection Risk after Sars-Cov-2 Vaccine Boosting in Patients with Plasma Cell Disorders: A Large Nationwide Veterans Affairs Study
por: Fillmore, Nathanael R, et al.
Publicado: (2022)

Prevalence and Outcome of COVID-19 Infection in Cancer Patients: A National Veterans Affairs Study
por: Fillmore, Nathanael R, et al.
Publicado: (2020)

Factors Associated With Severe COVID-19 Among Vaccinated Adults Treated in US Veterans Affairs Hospitals
por: Vo, Austin D., et al.
Publicado: (2022)

Association of COVID-19 Vaccination With SARS-CoV-2 Infection in Patients With Cancer: A US Nationwide Veterans Affairs Study
por: Wu, Julie Tsu-Yu, et al.
Publicado: (2021)

Inadequate Sars-Cov-2 Vaccine Effectiveness in Patients with Multiple Myeloma: A Large Nationwide Veterans Affairs Study
por: Fillmore, Nathanael R, et al.
Publicado: (2021)

Even after SARS-CoV-2 booster, there is increased COVID-19 breakthrough infection in patients with plasma cell disorders
por: Fillmore, Nathanael R., et al.
Publicado: (2023)

2656. Longitudinal Trends in Attributable Causes of Death Among US Veteran Patients with Documented SARS-CoV-2 Infection between January 2021 and March 2023
por: Trottier, Caitlin A, et al.
Publicado: (2023)

Factors associated with the speed and scope of diffusion of COVID-19 therapeutics in a nationwide healthcare setting: a mixed-methods investigation
por: La, Jennifer, et al.
Publicado: (2022)

Impact of prior SARS-CoV-2 infection on incidence of hospitalization and adverse events following mRNA SARS-CoV-2 vaccination: A nationwide, retrospective cohort study
por: Li, Lucy L., et al.
Publicado: (2022)

Increased COVID-19 breakthrough infection risk in patients with plasma cell disorders
por: La, Jennifer, et al.
Publicado: (2022)

Bringing New Meaning to the Term “Adaptive Trial”: Challenges of Conducting Clinical Research During the Coronavirus Disease 2019 Pandemic and Implications for Implementation Science
por: Branch-Elliman, Westyn, et al.
Publicado: (2020)

1562MO Effectiveness of COVID-19 vaccination in cancer patients: A nationwide Veterans Affairs study
por: Wu, J.T-Y., et al.
Publicado: (2021)

More data needed on efficacy and safety of monovalent vaccines against SARS-CoV-2 omicron variants
por: Monach, Paul A, et al.
Publicado: (2023)

Real-World Outcomes for Patients Treated With Immune Checkpoint Inhibitors in the Veterans Affairs System
por: La, Jennifer, et al.
Publicado: (2020)

Reconsidering ‘minimal risk’ to expand the repertoire of trials with waiver of informed consent for research
por: Monach, Paul A, et al.
Publicado: (2021)

Moving towards a precision approach for prevention of severe COVID-19
por: Branch-Elliman, Westyn, et al.
Publicado: (2023)

Sentiment analysis of medical record notes for lung cancer patients at the Department of Veterans Affairs
por: Elbers, Danne C., et al.
Publicado: (2023)

Prognostic value of the veterans affairs frailty index in older patients with non‐small cell lung cancer
por: Cheng, David, et al.
Publicado: (2022)

Contemporary Analysis of Electronic Frailty Measurement in Older Adults with Multiple Myeloma Treated in the National US Veterans Affairs Healthcare System
por: DuMontier, Clark, et al.
Publicado: (2021)

Automating surveillance for healthcare-associated infections: Rationale and current realities (Part I/III)
por: Shenoy, Erica S., et al.
Publicado: (2023)

The Veterans Affairs Precision Oncology Data Repository, a Clinical, Genomic, and Imaging Research Database
por: Elbers, Danne C., et al.
Publicado: (2020)

Pragmatic, adaptive clinical trials: Is 2020 the dawning of a new age?
por: Branch-Elliman, Westyn, et al.
Publicado: (2020)

Epidemiology of Cancer-Associated Venous Thromboembolism in Patients With Solid and Hematologic Neoplasms in the Veterans Affairs Health Care System
por: Martens, Kylee L., et al.
Publicado: (2023)

2126. Comparative Effectiveness of Infection Prevention Interventions for Reducing Procedure-Related Cardiac Device Infections: Insights from the VA CART Program
por: Asundi, Archana, et al.
Publicado: (2018)

Novel Method to Flag Cardiac Implantable Device Infections by Integrating Text Mining With Structured Data in the Veterans Health Administration’s Electronic Medical Record
por: Mull, Hillary J., et al.
Publicado: (2020)

Using the Pillars of Infection Prevention to Build an Effective Program for Reducing the Transmission of Emerging and Reemerging Infections
por: Branch-Elliman, Westyn, et al.
Publicado: (2015)

An application to support COVID-19 occupational health and patient tracking at a Veterans Affairs medical center
por: Fillmore, Nathanael R, et al.
Publicado: (2020)

Best Practices in Recruitment and Outreach to Women and Diverse Veterans for Coronavirus Research at the U.S. Department of Veterans Affairs
por: Klote, Mary M., et al.
Publicado: (2023)

How Are Emerging Data Translated Into Clinical Practice? A Mixed Methods Investigation of Coronavirus Disease 2019 Institutional Treatment Protocols
por: Asundi, Archana, et al.
Publicado: (2021)

Corrigendum to: An Application to Support COVID-19 Occupational Health and Patient Tracking at a Veterans Affairs Medical Center
por: Fillmore, Nathanael R, et al.
Publicado: (2020)

The future of automated infection detection: Innovation to transform practice (Part III/III)
por: Branch-Elliman, Westyn, et al.
Publicado: (2023)

Leveraging electronic data to expand infection detection beyond traditional settings and definitions (Part II/III)
por: Branch-Elliman, Westyn, et al.
Publicado: (2023)

Pandemic scientific data sharing recommendations: examining and re-imagining pre-print servers after the end of the world-wide emergency
por: Doron, Shira, et al.
Publicado: (2023)

Patient- reported reasons for non-participation in a COVID-19 therapeutics clinical trial: Findings from a multi-center investigation
por: Dassum, Samira Reyes, et al.
Publicado: (2023)

Outcomes of Veterans Treated in Veterans Affairs Hospitals vs Non–Veterans Affairs Hospitals
por: Yoon, Jean, et al.
Publicado: (2023)

2093. Utilizing Implementation Science to Identify Barriers and Facilitators to Implementing Harm Reduction Services in the Veterans Health Administration (VHA)
por: Harvey, Leah, et al.
Publicado: (2022)

The Science Behind Safe School Re-opening: Leveraging the Pillars of Infection Control to Support Safe Elementary and Secondary Education During the COVID-19 Pandemic
por: Schechter-Perkins, Elissa M, et al.
Publicado: (2021)

Risk factors of SARS-CoV-2 infection and complications from COVID-19 in lung cancer patients
por: Ganti, Apar Kishor, et al.
Publicado: (2023)

Implementation of documented and written informed consent for clinical trials of communicable diseases: Lessons learned, barriers, solutions, future directions identified during the conduct of a COVID-19 clinical trial
por: Woods, Patricia, et al.
Publicado: (2021)

Bronchopleural fistula due to cavitary pneumonia after SARS-CoV-2 infection treated with open thoracostomy
por: Belyayev, Leonid A, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_s5kcrf5uj8ljdbtf847cuuvc9a